Adial Pharmaceuticals, Inc. ADIL
ADIL
Adial Pharmaceuticals, Inc. APRE
Aprea Therapeutics, Inc. MTNB
Matinas BioPharma Holdings, Inc. NRSN
NeuroSense Therapeutics Ltd. SNGX
Soligenix, Inc. HCWB
HCW Biologics Inc. CUBT
Curative Biotechnology, Inc. BCLI
Brainstorm Cell Therapeutics Inc. BCDA
BioCardia, Inc. VYNE
VYNE Therapeutics Inc.
Adial Pharmaceuticals, Inc. APRE
Aprea Therapeutics, Inc. MTNB
Matinas BioPharma Holdings, Inc. NRSN
NeuroSense Therapeutics Ltd. SNGX
Soligenix, Inc. HCWB
HCW Biologics Inc. CUBT
Curative Biotechnology, Inc. BCLI
Brainstorm Cell Therapeutics Inc. BCDA
BioCardia, Inc. VYNE
VYNE Therapeutics Inc.
Performance
| Periode | ADIL | APRE | MTNB | NRSN | SNGX | HCWB | CUBT | BCLI | BCDA | VYNE |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -47.09 % | -5.70 % | 227.59 % | 16.98 % | -21.00 % | -48.09 % | -43.97 % | -11.31 % | -23.90 % | -79.20 % |
| YTD | -63.58 % | -58.26 % | 223.13 % | 7.83 % | -46.26 % | -76.02 % | -46.67 % | -67.76 % | -30.97 % | -88.63 % |
| 1Y | -59.36 % | -51.15 % | -45.40 % | 29.57 % | -56.11 % | -81.29 % | -46.67 % | -67.45 % | -36.07 % | -81.07 % |
| 3Y | -95.17 % | -89.79 % | -94.41 % | -24.39 % | -98.94 % | -95.28 % | -62.11 % | -98.63 % | -98.30 % | -91.34 % |
| 5Y | -99.22 % | -99.71 % | -95.63 % | -69.31 % | -99.62 % | -98.28 % | -44.62 % | -99.70 % | -98.54 % | -99.73 % |
| 10Y | -99.62 % | -99.64 % | -95.34 % | -69.31 % | -99.94 % | -98.28 % | 7 100.00 % | -98.39 % | -99.60 % | -99.98 % |
| From the beginning | -99.62 % | -99.64 % | -97.08 % | -69.31 % | -100.00 % | -98.28 % | -100.00 % | -72.73 % | -100.00 % | -99.98 % |